Patient preferences for lung and colorectal cancer therapy – a discrete choice experiment
A discrete choice experiment (DCE) is conducted to analyse the preferences of lung and colorectal cancer patients. Participants are asked to rank the attributes of medical therapy (effects and side effects) on the basis of choice sets depending on their preferences. Within this study, effects with high or low importance for patients in drug cancer therapy will be identified.
Funded by the Federal Ministry of Education and Research (BMBF).
The results of the study are accepted for publication in Patient Preference and Adherence.
Schmidt K, Damm K, Vogel A, Golpon H, Manns MP, Welte T, Graf von der Schulenburg JM. Therapy preferences of patients with lung and colon cancer: a discrete choice experiment.
Supplementary data can be found here.
Dr. Kathrin Damm